Get the Stockscreener App
1.98
5.26%
-0.11
After Hours:
2.07
0.09
+4.55%
Chemomab Therapeutics Ltd Adr Stock (CMMB) Forecast
The Chemomab Therapeutics Ltd Adr (CMMB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.33, representing a +623.97% increase from the current price of $1.98. The highest analyst price target is $13.97, and the lowest is $14.70.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CMMB Price Target
Average 14.06
(+610.25% Upside)
Is Chemomab Therapeutics Ltd Adr (CMMB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.17 | Neutral |
| STOCH(9,6) | 44.89 | Neutral |
| STOCHRSI(14) | 38.25 | Neutral |
| MACD(12,26) | 0.0321 | Sell |
| ADX(14) | 10.13 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -229.01 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.062
Sell
|
2.0524
Sell
|
| MA20 |
2.0535
Sell
|
2.0416
Sell
|
| MA50 |
1.9084
Buy
|
1.9266
Buy
|
| MA100 |
1.7133
Buy
|
1.7569
Buy
|
| MA200 |
1.4283
Buy
|
1.4888
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, CMMB could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CMMB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 45.17 indicates that CMMB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.89 indicates that CMMB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.25 indicates that CMMB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.13 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -229.01 indicates that CMMB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CMMB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Chemomab Therapeutics Ltd Adr financial reports and earnings history, Chemomab Therapeutics Ltd Adr (CMMB) stock could reach $21.18 by 2030, $79.52 by 2040 and $164.45 by 2050. See the projected annual prices until 2050 of the Chemomab Therapeutics Ltd Adr stock below:
- Chemomab Therapeutics Ltd Adr (CMMB) is expected to reach an average price of $79.43 in 2035, with a high prediction of $80.63 and a low estimate of $79.61. This indicates an $3,912% rise from the last recorded price of $1.98.
- Chemomab Therapeutics Ltd Adr (CMMB) stock is projected to chart a bullish course in 2040, with an average price target of $77.44, representing an $3,811% surge from its current level. The forecast ranges from a conservative $77.96 to a sky-high $79.52.
- Our analysts predict Chemomab Therapeutics Ltd Adr (CMMB) to jump 1,381% by 2045, soaring from $29.37 to an average price of $29.33, potentially reaching $31.72. While $29.37 is the low estimate, the potential upside is significant.
- Chemomab Therapeutics Ltd Adr (CMMB) stock is expected to climb by 2050, reaching an average of $163.05, a $8,135% jump from its current level. However, a wide range of estimates exists, with high and low targets of $164.45 and $163.12, respectively, highlighting the market's uncertainty.
Chemomab Therapeutics Ltd Adr Stock (CMMB) Year by Year Forecast
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2025
Chemomab Therapeutics Ltd Adr Stock (CMMB) is expected to reach an average price of $14.06 in 2025, with a high prediction of $16.03 and a low estimate of $12.09. This indicates an +610.25% rise from the last recorded price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $14.62 | $14.70 | $13.97 | +638.49% |
| April, 2025 | $16.11 | $15.97 | $15.72 | +713.88% |
| May, 2025 | $15.90 | $15.98 | $16.03 | +702.78% |
| June, 2025 | $14.49 | $14.60 | $15.26 | +631.58% |
| July, 2025 | $15.40 | $14.42 | $14.95 | +677.68% |
| August, 2025 | $14.93 | $15.19 | $15.18 | +653.95% |
| September, 2025 | $14.05 | $14.24 | $14.64 | +609.52% |
| October, 2025 | $13.47 | $13.56 | $13.18 | +580.37% |
| November, 2025 | $12.04 | $12.75 | $13.08 | +508.15% |
| December, 2025 | $11.84 | $12.09 | $12.32 | +498.19% |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2026
The predicted value for Chemomab Therapeutics Ltd Adr (CMMB) in 2026 is set at an average of $9.3325. Estimates vary from a peak of $12.30 to a trough of $6.367, indicating an +371.34% surge from the present price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.38 | $12.20 | $12.21 | +525.48% |
| February, 2026 | $12.09 | $12.12 | $12.30 | +510.59% |
| March, 2026 | $11.47 | $11.63 | $11.93 | +479.41% |
| April, 2026 | $10.44 | $10.86 | $11.22 | +427.15% |
| May, 2026 | $9.9479 | $10.03 | $10.02 | +402.42% |
| June, 2026 | $9.5481 | $9.5881 | $9.6804 | +382.23% |
| July, 2026 | $9.4009 | $9.4909 | $9.3806 | +374.79% |
| August, 2026 | $8.8711 | $8.8911 | $9.1885 | +348.03% |
| September, 2026 | $7.9738 | $8.1238 | $8.5036 | +302.72% |
| October, 2026 | $7.2341 | $7.5041 | $7.5164 | +265.36% |
| November, 2026 | $7.0593 | $7.1592 | $7.0566 | +256.53% |
| December, 2026 | $6.357 | $6.367 | $6.8268 | +221.06% |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Chemomab Therapeutics Ltd Adr (CMMB) is $12.58, with a high forecast of $24.95 and a low forecast of $0.1974. This indicates an +535.14% increase from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.9773 | $6.046 | $6.1597 | +201.88% |
| February, 2027 | $5.3675 | $5.4375 | $5.7799 | +171.08% |
| March, 2027 | $4.8902 | $4.9202 | $5.22 | +146.98% |
| April, 2027 | $4.5405 | $4.6046 | $4.7028 | +129.32% |
| May, 2027 | $4.0107 | $4.0307 | $4.2556 | +102.56% |
| June, 2027 | $3.2845 | $3.3028 | $3.8632 | +65.89% |
| July, 2027 | $2.6367 | $2.7237 | $3.0861 | +33.16% |
| August, 2027 | $1.8989 | $2.0729 | $2.4852 | -4.10% |
| September, 2027 | $1.1165 | $1.1356 | $1.7564 | -43.61% |
| October, 2027 | $0.6169 | $0.6943 | $0.9393 | -68.85% |
| November, 2027 | $27.26 | $0.1974 | $23.38 | +1,277% |
| December, 2027 | $24.93 | $25.11 | $24.95 | +1,159% |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2028
In 2028, Chemomab Therapeutics Ltd Adr (CMMB) is projected to reach an average price of $34.10, with a high projection of $36.75 and a low estimate of $31.45. This indicates an +1,622% rise from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $35.62 | $35.01 | $35.36 | +1,699% |
| February, 2028 | $31.39 | $31.45 | $32.53 | +1,485% |
| March, 2028 | $32.93 | $33.30 | $31.90 | +1,563% |
| April, 2028 | $37.31 | $34.20 | $34.89 | +1,784% |
| May, 2028 | $35.02 | $34.27 | $33.40 | +1,669% |
| June, 2028 | $37.61 | $35.79 | $35.84 | +1,799% |
| July, 2028 | $35.89 | $36.05 | $36.75 | +1,713% |
| August, 2028 | $36.53 | $36.05 | $35.32 | +1,745% |
| September, 2028 | $36.09 | $36.47 | $35.46 | +1,723% |
| October, 2028 | $37.09 | $35.90 | $36.03 | +1,773% |
| November, 2028 | $36.30 | $36.80 | $36.48 | +1,733% |
| December, 2028 | $34.68 | $35.36 | $35.68 | +1,652% |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2029
The 2029 price forecast for Chemomab Therapeutics Ltd Adr Stock (CMMB) is $27.66 on average, with a high prediction of $33.53 and a low estimate of $21.79. This represents an +1,297% increase from the previous price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $33.88 | $33.56 | $33.48 | +1,611% |
| February, 2029 | $33.72 | $33.95 | $33.53 | +1,603% |
| March, 2029 | $31.94 | $32.25 | $32.94 | +1,513% |
| April, 2029 | $30.45 | $30.64 | $31.17 | +1,438% |
| May, 2029 | $29.62 | $29.82 | $30.10 | +1,396% |
| June, 2029 | $28.13 | $28.44 | $28.38 | +1,321% |
| July, 2029 | $27.31 | $27.35 | $27.80 | +1,279% |
| August, 2029 | $26.84 | $26.92 | $27.07 | +1,256% |
| September, 2029 | $25.58 | $25.73 | $26.30 | +1,192% |
| October, 2029 | $23.79 | $24.38 | $24.94 | +1,101% |
| November, 2029 | $22.75 | $22.83 | $23.20 | +1,049% |
| December, 2029 | $21.53 | $21.79 | $22.37 | +987.17% |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2030
Chemomab Therapeutics Ltd Adr Stock (CMMB) is expected to reach an average price of $14.63 in 2030, with a high forecast of $21.18 and a low forecast of $8.0716. This signifies an +638.70% surge from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $20.80 | $20.85 | $21.18 | +950.58% |
| February, 2030 | $19.56 | $19.77 | $20.16 | +887.98% |
| March, 2030 | $18.37 | $18.47 | $19.24 | +827.90% |
| April, 2030 | $17.02 | $17.31 | $18.00 | +759.48% |
| May, 2030 | $15.63 | $15.83 | $16.69 | +689.31% |
| June, 2030 | $14.75 | $14.93 | $15.31 | +644.89% |
| July, 2030 | $13.50 | $13.56 | $14.40 | +582.03% |
| August, 2030 | $12.36 | $12.43 | $13.20 | +524.48% |
| September, 2030 | $11.43 | $11.50 | $12.03 | +477.28% |
| October, 2030 | $10.12 | $10.27 | $11.12 | +411.02% |
| November, 2030 | $9.1161 | $9.241 | $9.7758 | +360.41% |
| December, 2030 | $7.9866 | $8.0716 | $8.7462 | +303.36% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):